General: Solutions of Albumin should not be used if they appear turbid or if there is sediment in the bottle. Contents must not be used more than four hours after the container has been penetrated. Discard unused portion.
Medical products prepared from human plasma carry a very remote risk of transmission of infective agents that are reduced by several methodologies.
Albumin should be administered with caution to patients with low cardiac reserve.
Rapid infusion may cause vascular overload with resultant pulmonary edema. Patients should be closely monitored for signs of increased venous pressure.
Patients with marked dehydration require administration of additional fluids. Albumin may be administered with the usual dextrose and saline intravenous solutions. However, solutions containing protein hydrolysates or alcohol must never be infused through the same administration set in conjunction with Human Albumin since these combinations may cause precipitation of proteins.
Use in Children: Appropriate dose based on body weight is not known to cause any undesirable effect.
Other Services
Country
Account